CVS Health Corp.’s growth through acquisitions has given it a stock edge over competitors with just retail operations, like Walgreens Boots Alliance Inc., and pure pharmacy-management companies, like Express Scripts Holding Co. The Woonsocket, Rhode Island-based company reports first-quarter earnings Tuesday, with sales expected to climb 18 percent from the year-earlier period to $43 billion, according to the average of 20 analysts’ estimates. Adjusted earnings per share are seen rising to $1.16, the average of 23 analysts.
Photographer: David Paul Morris/Bloomberg
CVS Health Exhibits Healthy Stock Lead Year-to-Date: Chart
Before it's here, it's on the Bloomberg Terminal. LEARN MORE